The report provides a detailed analysis essential for establishing an Isosorbide Dinitrate production plant. It encompasses all critical aspects necessary for Isosorbide Dinitrate production, including the cost of Isosorbide Dinitrate production, Isosorbide Dinitrate plant cost, Isosorbide Dinitrate production costs, and the overall Isosorbide Dinitrate production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating an Isosorbide Dinitrate production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Isosorbide dinitrate is a prescription medication belonging to the class of drugs known as nitrates. It is primarily used in the pharmaceutical industry as a vasodilator to treat and prevent angina pectoris, heart failure, severe hypertension, and oesophageal spasms. It works by relaxing vascular smooth muscle, leading to dilation of arteries and veins, which reduces cardiac workload and oxygen demand.
It is available in oral and sublingual dosage forms, including extended-release tablets, for both acute relief and long-term management of ischemic heart diseases. Beyond its medical uses, derivatives of isosorbide have industrial applications as plasticisers, surfactants, polymer stabilisers, and renewable solvents in sectors like cosmetics, cleaning agents, and environmentally friendly additives.
The market for isosorbide dinitrate is primarily driven by the rising global prevalence of cardiovascular diseases such as angina pectoris and heart failure, which increases the demand for effective vasodilator medications. Ageing populations worldwide, especially in developed regions like North America and Europe, contribute significantly to the expanding patient base.
Additionally, growing healthcare expenditures, government health initiatives promoting cardiovascular disease management, and advancements in drug formulations and delivery methods further fuel market growth. Emerging markets in the Asia-Pacific region, with increasing healthcare access and rising environmental awareness, also present new growth opportunities. Furthermore, ongoing research in personalised medicine and integration with healthcare technologies expands therapeutic applications and improves patient outcomes.
Investment in advanced purification and synthesis technologies to meet ultra-high purity standards, which affect supplier selection based on technological capabilities and cost efficiencies, impacts industrial isosorbide dinitrate procurement. Also, the limited availability of pharmaceutical-grade isosorbide in certain global regions leads to periodic shortages, necessitating strategic stockpiling and long-term supplier contracts, which further influence the overall procurement.
Raw Material for Isosorbide Dinitrate Production
According to the Isosorbide Dinitrate production plant project report, the raw material for Isosorbide Dinitrate production includes D-sorbitol.
Production Process of Isosorbide Dinitrate
The extensive Isosorbide Dinitrate production cost report consists of the following major industrial production process:
- Production from D-sorbitol: The production process of isosorbide dinitrate involves several stages, starting with D-sorbitol, derived from catalytic hydrogenation of glucose. D-sorbitol undergoes intermolecular dehydration using catalysts such as paratoluenesulfonic acid or sulfated zirconium to produce isosorbide. This step requires controlled temperature and catalyst management to achieve selective dehydration. After purification of isosorbide, it is nitrated using a mixture of concentrated nitric and sulfuric acids under precise temperature and molar ratio controls to introduce nitrate groups on the two hydroxyl sites, forming isosorbide dinitrate.
Properties of Isosorbide Dinitrate
Isosorbide dinitrate is an ivory-white crystalline solid with the chemical formula C6H8N2O8 and a molecular weight of 236.14 g/mol. It is odourless and stable in air and solution. The compound has a melting point around 70-71 degree Celsius. It is sparingly soluble in water but freely soluble in organic solvents such as acetone, chloroform, alcohol, and ether.
The molecule contains a furan ring structure with four chiral centres, and it has moderate lipophilicity with an octanol/water partition coefficient of about 1.31. It is classified as an organic nitrate used mainly as a vasodilator in pharmaceuticals. Its pharmacological action stems from enzymatic conversion to nitric oxide, which triggers smooth muscle relaxation and vasodilation. The compound is moderately stable and requires handling precautions consistent with nitrate drugs.
